DOCSLIB.ORG

Advances in Me/Cfs Research and Clinical Care

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Advances in Me/Cfs Research and Clinical Care ADVANCES IN ME/CFS RESEARCH AND CLINICAL CARE EDITED BY : Kenneth J. Friedman, Lucinda Bateman, Alison Bested and Zaher Nahle PUBLISHED IN : Frontiers in Pediatrics and Frontiers in Neurology Frontiers eBook Copyright Statement About Frontiers The copyright in the text of individual articles in this eBook is the Frontiers is more than just an open-access publisher of scholarly articles: it is a property of their respective authors or their respective institutions or pioneering approach to the world of academia, radically improving the way scholarly funders. The copyright in graphics research is managed. The grand vision of Frontiers is a world where all people have and images within each article may be subject to copyright of other an equal opportunity to seek, share and generate knowledge. Frontiers provides parties. In both cases this is subject immediate and permanent online open access to all its publications, but this alone to a license granted to Frontiers. is not enough to realize our grand goals. The compilation of articles constituting this eBook is the property of Frontiers. Frontiers Journal Series Each article within this eBook, and the eBook itself, are published under The Frontiers Journal Series is a multi-tier and interdisciplinary set of open-access, the most recent version of the Creative Commons CC-BY licence. online journals, promising a paradigm shift from the current review, selection and The version current at the date of dissemination processes in academic publishing. All Frontiers journals are driven publication of this eBook is CC-BY 4.0. If the CC-BY licence is by researchers for researchers; therefore, they constitute a service to the scholarly updated, the licence granted by community. At the same time, the Frontiers Journal Series operates on a revolutionary Frontiers is automatically updated to the new version. invention, the tiered publishing system, initially addressing specific communities of When exercising any right under the scholars, and gradually climbing up to broader public understanding, thus serving CC-BY licence, Frontiers must be the interests of the lay society, too. attributed as the original publisher of the article or eBook, as applicable. Dedication to Quality Authors have the responsibility of ensuring that any graphics or other Each Frontiers article is a landmark of the highest quality, thanks to genuinely materials which are the property of collaborative interactions between authors and review editors, who include some others may be included in the CC-BY licence, but this should be of the world’s best academicians. Research must be certified by peers before entering checked before relying on the CC-BY licence to reproduce those a stream of knowledge that may eventually reach the public - and shape society; materials. Any copyright notices therefore, Frontiers only applies the most rigorous and unbiased reviews. relating to those materials must be complied with. Frontiers revolutionizes research publishing by freely delivering the most outstanding Copyright and source research, evaluated with no bias from both the academic and social point of view. acknowledgement notices may not By applying the most advanced information technologies, Frontiers is catapulting be removed and must be displayed in any copy, derivative work or scholarly publishing into a new generation. partial copy which includes the elements in question. All copyright, and all rights therein, What are Frontiers Research Topics? are protected by national and Frontiers Research Topics are very popular trademarks of the Frontiers Journals international copyright laws. The above represents a summary only. Series: they are collections of at least ten articles, all centered on a particular subject. For further information please read With their unique mix of varied contributions from Original Research to Review Frontiers’ Conditions for Website Use and Copyright Statement, and Articles, Frontiers Research Topics unify the most influential researchers, the latest the applicable CC-BY licence. key findings and historical advances in a hot research area! Find out more on how ISSN 1664-8714 to host your own Frontiers Research Topic or contribute to one as an author by ISBN 978-2-88963-206-0 DOI 10.3389/978-2-88963-206-0 contacting the Frontiers Editorial Office: [email protected] Frontiers in Pediatrics 1 November 2019 | ME/CFS Research and Clinical Care ADVANCES IN ME/CFS RESEARCH AND CLINICAL CARE Topic Editors: Kenneth J. Friedman, Retired, New Jersey Medical School, United States Lucinda Bateman, Bateman Horne Center, Salt Lake City, United States Alison Bested, Nova Southeastern University, United States Zaher Nahle, Arthritis National Research Foundation, United States About the Art The name of the painting is “Bring me along”. I stand in the dark, urging to be alive, please bring me along in your light. ME/CFS is a place of darkness. It is complete in both physical and mental state... Even light itself can make a person exhausted. Despite such darkness, patients reach out for help. Modified comments of the artist. About the Artist Solveig Evelyn Hopland is a Norwegian artist who paints in both romantic and surreal styles. Surreal painting allows her to express personal philosophies of what is important in life, and the big perspective of our existence. Image: Solveig E. Hopland. Frontiers in Pediatrics 2 November 2019 | ME/CFS Research and Clinical Care In 2015, the Institute of Medicine (USA) issued a report critical of the research effort and clinical care for ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) formerly known as Chronic Fatigue Syndrome (CFS) and Chronic Fatigue Immune Deficiency Syndrome (CFIDS). While worldwide investigation into the cause and nature of ME/CFS remains disproportionately small, and treatment remains symptomatic and controversial, modest research continues in all aspects of this disease: epidemiology, possible infectious origins and other triggers, possible involvement of genetics, metabolism, and microbiome, influence of co-morbid conditions, and more. Treatment of patients consists of providing symptomatic relief. Guidance in doing so is provided for the clinician. School-age children require not only treatment but, as revealed in a 25-year retrospective study, continued engagement with peers and social activity. This e-book explores the breadth and depth of current ME/CFS research and clinical care. Its impact for other chronic, complex illnesses should not be overlooked. Citation: Friedman, K. J., Bateman, L., Bested, A., Nahle, Z., eds. (2019). Advances In ME/CFS Research and Clinical Care. Lausanne: Frontiers Media SA. doi: 10.3389/978-2-88963-206-0 Frontiers in Pediatrics 3 November 2019 | ME/CFS Research and Clinical Care Table of Contents 07 Editorial: Advances in ME/CFS Research and Clinical Care Kenneth J. Friedman, Lucinda Bateman, Alison Bested and Zaher Nahle INTRODUCTION 10 Advances in ME/CFS: Past, Present, and Future Kenneth J. Friedman CAUSES AND TRIGGERS 18 Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Lily Chu, Ian J. Valencia, Donn W. Garvert and Jose G. Montoya 40 Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study Melanie Perez, Rajeev Jaundoo, Kelly Hilton, Ana Del Alamo, Kristina Gemayel, Nancy G. Klimas, Travis J. A. Craddock and Lubov Nathanson 47 Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Jonathan R. Kerr DISEASE CHARACTERIZATION - CASE DEFINITION 58 The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions Leonard A. Jason and Madison Sunnquist 67 The Importance of Accurate Diagnosis of ME/CFS in Children and Adolescents: A Commentary Keith James Geraghty and Charles Adeniji VALIDATING THE ME/CFS DIAGNOSIS 72 Hand Grip Strength as a Clinical Biomarker for ME/CFS and Disease Severity Luis Carlos Nacul, Kathleen Mudie, Caroline C. Kingdon, Taane G. Clark and Eliana Mattos Lacerda 82 Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Staci Stevens, Chris Snell, Jared Stevens, Betsy Keller and J. Mark VanNess 92 Low Sensitivity of Abbreviated Tilt Table Testing for Diagnosing Postural Tachycardia Syndrome in Adults With ME/CFS C. (Linda) M. C. van Campen, Peter C. Rowe and Frans C. Visser Frontiers in Pediatrics 4 November 2019 | ME/CFS Research and Clinical Care EPIDEMIOLOGY 98 Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning Ashley R. Valdez, Elizabeth E. Hancock, Seyi Adebayo, David J. Kiernicki, Daniel Proskauer, John R. Attewell, Lucinda Bateman, Alfred DeMaria Jr., Charles W. Lapp, Peter C. Rowe and Charmian Proskauer LABORATORY RESEARCH 112 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity Amy Proal and Trevor Marshall 131 Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods Michael B. VanElzakker, Sydney A. Brumfield and Paula S. Lara Mejia 160 Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
Load more

Recommended publications
  • Sensationalism Versus Science?
    Sensationalism versus Science? Malcolm Hooper and Margaret Williams 5th May 2013 The long-promised article by Michael Hanlon on the “war” surrounding the neuroimmune disorder myalgic encephalomyelitis (ME) was published today in the Sunday Times Magazine together with a photograph of Professor Sir Simon Wessely (“This man faced death threats and abuse. His crime? He suggested that ME was a mental illness”). Whilst the article focuses on the unacceptable actions of very few alleged sufferers and not on legitimate challenges mounted by scientists, it may be of interest to reproduce the questions which Hanlon sent to Professor Malcolm Hooper on 31st January and also Professor Hooper’s reply, since that reply provides the backdrop to the on-going “war”. First, though, it must be said that much of Hanlon’s article is factually wrong. For example, Hanlon begins his article with the assertion that “Professor Sir Simon Wessely lives on the front line of science”,which immediately reveals a lack of understanding in that Sir Simon does not live on the front line of biomedical science but on the front line of psychiatry, a discipline with no biomarkers of disease. Indeed Sir Simon ignores, actively denies or dismisses the evidence of biomedical scientists that demonstrates whole-body inflammation in ME and does not accept that it has now been shown to be an autoimmune disease. Hanlon goes on to state that Sir Simon “has done a lot of work for the military, helping to treat traumatised war veterans”, when there is irrefutable published evidence that Sir Simon has for decades denied the very existence of Gulf War Syndrome.
    [Show full text]
  • Myalgic Encephalomyelitis Treatment and Research
    DEBATE PACK Number CDP 2018-0155, 18 June 2018 Myalgic By Dr Sarah Barber Nikki Sutherland Encephalomyelitis Dr Rachael Harker treatment and research Contents This pack has been prepared ahead of the debate to be held in Westminster Hall 1. Summary 2 on Thursday 21 June 2018 at 1.30pm on Myalgic Encephalomyelitis treatment 1.1 Background 2 1.2 Treatment 3 and research. The subject for the debate has been selected by the Backbench Services for CFS/ME 4 Business Committee and the debate will be opened by Carol Monaghan MP. Clinical guidelines 5 1.3 Research 7 Government funding for CFS/ME research 8 2. News items 10 3. Press releases 12 4. Parliamentary material 26 Debate 26 PQs 26 5. Useful links and further reading 38 The House of Commons Library prepares a briefing in hard copy and/or online for most non-legislative debates in the Chamber and Westminster Hall other than half-hour debates. Debate Packs are produced quickly after the announcement of parliamentary business. They are intended to provide a summary or overview of the issue being debated and identify relevant briefings and useful documents, including press and parliamentary material. More detailed briefing can be prepared for Members on request to the Library. www.parliament.uk/commons-library | intranet.parliament.uk/commons-library | [email protected] | @commonslibrary 2 Number CDP 2018-0155, 18 June 2018 1. Summary A debate on Myalgic Encephalomyelitis: Treatment and Research will take place in Westminster Hall on 21 June 2018. The debate will be led by Carol Monaghan MP.
    [Show full text]
  • New ME Briefing 21 J
    1 Briefing for ‘Myalgic Encephalomyelitis: Treatment st and Research’ Westminster Hall, 21 ​ June 2018 ​ Contents About ME 3 ​ The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME ​ ​ ​ ​ ​ Association and the ME Trust (for contact details, see page 15) ​ ​ ​ ​ ​ Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, ​ ​ ​ ​ ​ Forward-ME, ME Research UK, WAMES ​ ​ ​ ​ 2 A bout ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ​ ​ ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate. An estimated one in four children and adults with ME experience these symptoms severely (see ‘Severe ME’ on page 7).
    [Show full text]
  • Straight-Jacketed by Empty Air
    Straight-jacketed by empty air Psychiatry’s long and shameful involvement in Myalgic Encephalomyelitis St Straight-jacketed by empty air Greg Crowhurst Please note that the publisher and the author cannot be held accountable for any damages or actions arising from reading this book, which is presented for informational purposes only. It is not intended as a substitute for professional medical advice. The views of contributors are not necessarily those of the publisher or author, under no circumstances can they be held accountable for any loss or claim arising out of the opinions expressed or suggestions made. “There is no doubt that ME is an organic disorder. The sufferers are denied proper recognition, misdiagnosed, vilified, ridiculed and driven to great depths of despair.” Hansard (House of Commons) 23rd February 188/columns 167-168 Books by Greg Crowhurst : Kevin Mayhew : St Pauls : Holy Way , Stonebird S Stonebird Holy Way Dedication I dedicate this, with all the love in my heart to my wife Linda, whose agony is beyond imagination or comprehension. All I have to help are these arms to reach out, hold and comfort, but that is more and more unbearable for her to cope with, so severe is her torture. Acknowledgements: Many, many thanks for all the support and enthusiasm for this book, it spurred me on! Special thanks to Rachel Higginson, Susanna Agardy, Geoffrey Keith Brown, Sally K Burch, Colleen Steckel, Nancy Blake, Corina Duyn, Clare Norton, Naomi Whittingham and Theresa Brennan. “I must emphasise that the most important message
    [Show full text]
  • The Biopolitics of Chronic Fatigue Syndrome
    The Biopolitics of Chronic Fatigue Syndrome Thesis submitted for the degree of Doctor of Philosophy at the University of Leicester by Nikos Karfakis School of Management University of Leicester March 2013 Abstract The Biopolitics of Chronic Fatigue Syndrome by Nikos Karfakis This thesis approaches Chronic Fatigue Syndrome (CFS) as a biopolitical problem, that is as a shifting scientific object which needs to be studied, classified and regulated. Assemblages of authorities, knowledges, and techniques make CFS subjects and shape their everyday conduct in an attempt to increase their supposed autonomy, wellbeing and health. CFS identities are, however, made not only through government, scientific and medical interventions but also by the patients themselves, a biosocial community that collaborates with scientists, educates itself about the intricacies of biomedicine, and contests psychiatric truth claims. CFS is a socio-medical disorder, an illness trapped between medicine, psychology and society, an illness that is open to debate, and therefore difficult to manage and standardise. CFS is, thus, more than a fixed and defined medical category; it is a performative and multiple category, it is a heterogeneous world. This thesis studies that performative complexity by assembling different pieces of empirical data that constitute its heterogeneity: medical and psychiatric journals and monographs, self-help books, CFS organisations’ magazines, newsletters and websites, illness narratives and social studies of CFS, CFS blogs, and qualitative interviews with diagnosed CFS patients and CFS activists. The thesis delineates different interventions by medicine, science, the state and the patients themselves and concludes that CFS remains elusive, only partially standardised, in an on- going battle between all the different actors that want to define it for their own situated interests.
    [Show full text]
  • Journal of Iime Volume 1 Issue 1 2
    JJJooouuurrrnnnaaalll ooofff IIIiiiMMMEEE IIInnnvvveeesssttt iiinnn MMMEEE IIInnnttteeerrrnnnaaatttiiiooonnnaaalll MMMEEE///CCCFFFSSS CCCooonnnfffeeerrreeennnccceee 222000000777 SSSpppeeeccciiiaaalll VOLUME 1 ISSUE 1 Invest in ME Charity Nr 1114035 www.investinme.org Journal of IiME Volume 1 Issue 1 2 Welcome from Invest in ME Welcome to the first Journal of Invest in ME – a combination of research, information, news, stories and other articles relating to myalgic encephalomyelitis (ME). Facts About ME This first version is also serving a dual purpose in that it is acting as a An estimated 250,000 component of the delegate’s conference pack for the 2nd Invest in ME International ME/CFS Conference 2007, held in Westminster, London, UK. people suffer from ME in the UK Invest in ME welcomes delegates, presenters and media from ten countries around the world to the conference – emphasising that ME recognises no international boundaries. The interest in the conference also demonstrates the need for some of IiME’s main objectives – more education and proper funding for biomedical research into ME. In this document we include articles from renowned ME experts who ME Story were not able to be present at the conference this year as well as those who are. We also include other ME experts who are presenting. IiME I fell ill with the flu the hope to publish our journal throughout the year. As with the IiME same time as Antony, conference it will allow a platform for researchers, scientists, healthcare my then staff and politicians to be able to share and provide information boyfriend/fiancé. He relevant to those supporting, campaigning for or suffering from ME.
    [Show full text]
  • Parliamentary-Briefi
    1 Briefing for ‘Myalgic Encephalomyelitis: Treatment and Research’ Westminster Hall, 21st June 2018 Contents About ME 3 The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME Association and the ME Trust (for contact details, see page 15) Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, Forward-ME, ME Research UK, WAMES, Hope 4 ME & Fibro Northern Ireland 2 About ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate.
    [Show full text]
  • Parliamentary Briefing
    1 BRIEFING FOR MYALGIC ENCEPHALOMYELITIS: 'TREATMENT AND RESEARCH' WESTMINSTER HALL, 21 JUNE 2018. (This briefing has been reproduced without amendment for the Back Bench Business debate on 24 Jan 2019) Contents About ME 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME Association and the ME Trust (for contact details, see page 15) Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, Forward-ME, ME Research UK, Tymes Trust, WAMES, Hope 4 ME & Fibro Northern Ireland, 25% M.E. Group 2 About ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems.
    [Show full text]
  • Briefing for ‘Myalgic Encephalomyelitis: Treatment St and Research’ Westminster Hall, 21 ​ June 2018 ​
    1 Briefing for ‘Myalgic Encephalomyelitis: Treatment st and Research’ Westminster Hall, 21 ​ June 2018 ​ Contents About ME 3 ​ The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME ​ ​ ​ ​ ​ Association and the ME Trust (for contact details, see page 15) ​ ​ ​ ​ ​ Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, ​ ​ ​ ​ ​ Forward-ME, ME Research UK, WAMES, Hope 4 ME & Fibro Northern Ireland ​ ​ ​ ​ ​ ​ 2 A bout ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ​ ​ ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate.
    [Show full text]
  • The Psychological Aspects and Management of Chronic Fatigue Syndrome
    THE PSYCHOLOGICAL ASPECTS AND MANAGEMENT OF CHRONIC FATIGUE SYNDROME A Thesis submitted for the degree of Doctor of Philosophy by Ellen Marianne Goudsmit Department of Human Sciences, Brunel University February 1996 ACKNOWLEDGEMENTS The three studies could not have been completed without the help of a large number of people. First of all, I would like to thank my supervisors, Dr. Colette Ray and Mr. Ian Robinson, who have guided me with great skill and infinite patience. I am also grateful to Dr. Elizabeth Dowsett, Dr. Gordon Parish and Dr. Darryl Ho-Yen, who not only gave me practical assistance and scientific advice, but who also encouraged and supported me throughout. Thanks are also due to Lorna Wycherley for sending out the questionnaires for Study 3, to the staff at Richmond and Teddington libraries who obtained several hundred articles and books for me, to the Training Agency who loaned me a computer and printer, to Dr. Inge Heinrich and the support team at Brunel's Computer Centre for their statistical advice, to Frouke Bates and to Action for M.E. who funded Study 2. Finally, I wish to thank my parents, Abraham and Felicie Goudsmit, for all their help during the past six years, my friends, Deana Goff and Sandra Howes for their continuing interest and support and my colleagues, Drs. Charles Shepherd and Anne Macintyre for helping me make sense of a very complex subject. Most of all, I would like to thank everyone who took part in the studies for their time and their trust. Without their co-operation, this research would not have been possible.
    [Show full text]
  • NAM Chronic Fatigue Syndrome
    This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=19012 Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness ISBN Committee on the Diagnostic Criteria for Myalgic 978-0-309-31689-7 Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine 330 pages 6 x 9 PAPERBACK (2015) Visit the National Academies Press online and register for... Instant access to free PDF downloads of titles from the NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL 10% off print titles Custom notification of new releases in your field of interest Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Request reprint permission for this book Copyright © National Academy of Sciences. All rights reserved. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness Beyond Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Redefining an Illness Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Board on the Health of Select Populations PREPUBLICATION COPY—Uncorrected Proofs Copyright © National Academy of Sciences. All rights reserved. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Govern- ing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineer- ing, and the Institute of Medicine.
    [Show full text]
  • THE POWER of PROPAGANDA ? Compiled by Margaret Williams 4Th February 2017 for the Last 48 Years
    THE POWER OF PROPAGANDA ? Compiled by Margaret Williams 4th February 2017 www.margaretwilliams.me For the last 48 years, myalgic encephalomyelitis (ME) has been formally classified by the World Health Organisation as a neurological disorder but for the last 29 years a group of UK psychiatrists (known as the Wessely School) have denied it exists other than as an aberrant belief; they insist that it is a mental (behavioural) disorder that can be cured by graded exercise and “cognitive re-structuring”. “It’s absolutely retrogressive to suggest (ME)CFS is in the heads of patients. I have seen patients commit suicide, or have been otherwise destroyed, because some professor has diagnosed them as having a psychiatric illness” (Peter Behan, Professor of Clinical Neurology, University of Glasgow; New Scientist, May 1994) “It is one of the most disabling diseases that I care for, far exceeding HIV disease except for the terminal stages” (Dr Daniel Peterson, ME/CFS Research & Clinical Conference, Florida, October 1994) (ME/CFS patients) “feel effectively the same every day as an AIDS patient feels two months before death; the only difference is that the symptoms can go on for never-ending decades” (Professor Mark Loveless, Head of AIDS & ME/CFS, Oregon Health Sciences University – Congressional Briefing 1995) “Individuals are often stigmatized and told their illness isn’t real…People with (ME)CFS face an incredible burden just getting doctors to take their symptoms seriously” (Dr Barry Hurwitz, University of Miami: Co-Cure MED: 30th July 2003)
    [Show full text]